First Commonwealth Financial Corp’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$406K Sell
6,466
-41
-0.6% -$3.28K 0.06% 198
2025
Q4
$620K Buy
6,507
+13
+0.2% +$1.27K 0.1% 158
2025
Q3
$634K Sell
6,494
-401
-6% -$41.5K 0.11% 153
2025
Q2
$741K Hold
6,895
0.16% 125
2025
Q1
$696K Buy
6,895
+4,426
+179% +$446K 0.16% 124
2024
Q4
$221K Buy
+2,469
New +$217K 0.05% 207

Other funds holding BSX

First Commonwealth Financial Corp's BSX Position: Q1 2026 in Review

First Commonwealth Financial Corp reduced its Boston Scientific (BSX) stake by 0.63% in Q1 2026, selling an estimated $3.28K and leaving 6,466 shares worth $406K. The position accounts for 0.06% of the portfolio, ranked #198.

First Commonwealth Financial Corp first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $741K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • First Commonwealth Financial Corp held 6,466 shares of Boston Scientific worth $406K as of Q1 2026.
  • First Commonwealth Financial Corp sold 41 Boston Scientific shares in Q1 2026, an estimated $3.28K.
  • Boston Scientific made up 0.06% of First Commonwealth Financial Corp's portfolio in Q1 2026, its #198 holding.
  • First Commonwealth Financial Corp first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • First Commonwealth Financial Corp's Boston Scientific position peaked at $741K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on First Commonwealth Financial Corp's 13F filing for Q1 2026, filed 14 May 2026.